Rheumatoid is an intractable disease and is listed by the World Health Organization as one of the five major incurable diseases of human beings, which shows the difficulty of its treatment.

At present, the main medical treatment is to relieve joint pain, prevent joint destruction, and retain and improve joint function.

But now Su Zhe has come up with a formula that can cure rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, gouty arthritis, ankylosing spondylitis, reactive arthritis, infectious arthritis, and other diseases, such as traumatic arthritis, psoriatic arthritis, enteropathic arthritis and dozens of other inflammatory diseases, can be effectively treated.

And this is just one formula that can cure all arthritis, and for this alone, there is no drug on the market that can do it.

Not to mention the therapeutic effect of this formula, it is unprecedentedly good, it can be said that there is no similar drug that can compare to Su Zhe's one.

Therefore, the formula that Su Zhe brought now, Li Changhua and Liu Xiong believed, its value would not be lower than that of the Blue Elixir, and it might even be even higher.

Therefore, it is conceivable how much impact this formula, if it is successfully launched, will have a big impact.

Therefore, Li Changhua and Liu Xiong were so shocked in the conference room.

The most important thing is that Su Zhe's formula is extremely cheap to produce, and it can also be produced in large quantities.

At present, there is a foreign drug on the market, the indications of which are rheumatoid arthritis, Crohn's disease, obligatory spondylitis, psoriasis, ulcerative colitis, which is one of the 25 best-selling drugs in the world.

This is the flagship product of a foreign pharmaceutical giant. It has been the world's highest-selling drug champion for several consecutive years. Huge profits were made for the pharmaceutical company.

This one of the drugs is an injection. A 40mg specification costs as much as 7,900 yuan, and it needs to be injected every two weeks, and the cost is as high as 200,000 yuan a year.

If the patient has a decrease in the effectiveness of the treatment, the dose of the drug needs to be increased to 40 mg per week to improve the efficacy, which is a lot more expensive.

An injection is 7,900 yuan. For many people, at least for many families in China, it is difficult to accept and afford.

After all, the treatment is definitely not just an injection, the disease can be cured, it must be treated for a long time.

In this case, it is conceivable how many people cannot afford to buy medicine because it is too expensive. Can't cure the disease.

So, although there are many diseases. Effective treatments have been developed, but for many people, they are still the same as before, and they simply cannot afford to use them, which makes people even more desperate.

Li Changhua and Liu Xiong can imagine that if the formula that Su Zhe now masters is pushed to the drug market, it will cause a lot of big turmoil, because there will be many drugs that will be affected and affected.

Moreover, the formula that Su Zhe took out will not have the side effects of similar drugs, and there is no treatment risk at all.

The most important thing is that the production cost of this formula is not high, with Su Zhe's past style, then after this drug is launched, the price will definitely not be high, and it will definitely be countless times cheaper than similar drugs.

In this way, the change to the market is very big.

Su Zhe just thought of how many people this formula could help, but Li Changhua and Liu Xiong thought of how much impact this formula would have on the current drug market.

"Try to develop this formula and then push it to the market in the shortest possible time." After Su Zhe introduced the formula to Li Changhua and Liu Xiong, he said.

"Can the potion used to produce this recipe be guaranteed?" From Su Zhe's introduction just now, Li Changhua knew that the production of this formula also required healing potions, so he only asked now.

"I'll solve the problem of the potion, you just need to make it as good as possible." Su Zhe replied.

At present, the drugs produced by Changhua Pharmaceutical need to meet domestic and foreign needs, and in terms of current output, the treatment potion required a month is about 120 million milliliters.

And this is the minimum standard, calculated based on the current production plan, if the production plan is increased, then the number of healing potions required is far more than that.

However, Su Zhe refined more than 9 million milliliters of healing potions in a day, and at least 270 million milliliters a month.

Even if you remove the healing potions needed by the Yadai Group, there is still a lot of amateurism, at least about 100 million milliliters left.

So Su Zhe was not worried about not having a healing potion to produce new medicines.

Therefore, Su Zhe's request is to try to make this new formula successfully enter the market, and the sooner it enters the market, the greater the benefits for many patients.

Even if Su Zhe couldn't make all the patients take this medicine, he didn't have so many healing potions to produce.

However, Su Zhe believes that as long as this new drug enters the market, it will definitely reduce the price of many similar drugs.

In fact, many best-selling drugs are extremely expensive, although the high cost of research and development is part of the reason.

But the main thing is that these best-selling drugs have no competitors, so they can sell them at the highest price and make the most profits.

If Changhua Pharmaceutical can bring new drugs to the market, then these best-selling drugs have competitors.

In the face of Changhua Pharmaceutical's low-price sales, these pharmaceutical companies can only choose to reduce prices, and they have faced the impact of Changhua Pharmaceutical.

This is not without examples, since Changhua Pharmaceutical has successively launched Sleep Pills, Awakening Pills, Thawing Pills, and Blue Pills, many drugs on the market have been greatly reduced in price.

There is no way to do this, because the drugs produced by Changhua Pharmaceutical not only have good therapeutic effects, but also are very cheap.

If the price of these similar drugs is not reduced, there will be no market at all.

This is also because of the production problem of Changhua Pharmaceutical, which cannot meet the needs of all patients. Therefore, there is room for the production of similar drugs on the market.

Otherwise, the sales of the drugs produced by Changhua Pharmaceutical would have been completely cut off.

Because Changhua Pharmaceutical has a great advantage in terms of price and treatment effect, other similar drugs are not a threat to Changhua Pharmaceutical at all.

Although Changhua Pharmaceutical has not had much impact on foreign markets.

However, at least in the domestic market, Changhua Pharmaceutical has had a great impact on many similar drugs.

Therefore, as long as Changhua Pharmaceutical Co., Ltd. launches new drugs, these patients will benefit more or less, so Su Zhe asked Li Changhua and them to develop this formula in the shortest possible time. (To be continued......)